Zhendong Xiang

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 12, 2021
Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death.

Zhendong Xiang, Yin Sun, Bosen You

Pageof 1

Frequent Collaborators

1 joint publications

Chawnshang Chang